Ck Life Sciences, also known as Ck Life Sciences International Holdings, is a prominent biotechnology company headquartered in Hong Kong. Founded in 2000, the company has established itself as a leader in the life sciences sector, focusing on innovative solutions in agricultural biotechnology and healthcare. With a strong presence in Asia and expanding operations globally, Ck Life Sciences is dedicated to developing unique products that enhance crop yields and improve human health. Their core offerings include advanced biopesticides and nutraceuticals, distinguished by their commitment to sustainability and efficacy. Recognised for its pioneering research and development, Ck Life Sciences has achieved significant milestones, positioning itself as a key player in the biotechnology industry. The company continues to drive advancements that contribute to a healthier and more sustainable future.
How does Ck Life Sciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Ck Life Sciences's score of 22 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Ck Life Sciences reported total carbon emissions of approximately 48,960,000 kg CO2e, with Scope 1 emissions at about 32,037,000 kg CO2e and Scope 2 emissions at around 16,923,000 kg CO2e. This represents a slight increase from 2022, where emissions were approximately 46,880,000 kg CO2e. Over the past few years, the company has shown fluctuations in its emissions, with a total of about 50,073,000 kg CO2e in 2021 and approximately 47,527,000 kg CO2e in 2020. Notably, the emissions in 2019 were around 44,583,000 kg CO2e. Despite these figures, Ck Life Sciences has not publicly disclosed specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of documented reduction targets suggests a need for enhanced climate commitments within the organisation. Overall, while Ck Life Sciences has made strides in tracking its emissions, the lack of defined reduction strategies may impact its long-term sustainability goals.
Access structured emissions data, company-specific emission factors, and source documents
Get Started2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Scope 1 | 28,483,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 2 | 16,100,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 3 | - | - | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ck Life Sciences is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.